Our pre-clinical data show that inhibitors of JAK1/JAK2 prevent diabetes and reverse newly diagnosed diabetes in the non-obese diabetic (NOD) mouse model of T1D [1, 2]. The gene discussed is JAK2; the disease is diabetes mellitus.